Ottobock SE & Co. KGaA
Ottobock SE & Co. KGaA designs and develops medical technology products and solutions for the people with limited mobility in the fields of prosthetics, orthotics, human mobility, and medical care worldwide. The company develops exo-prosthetics products, including microprocessor-controlled lower limb prosthesis systems, bionic prosthetic systems, michelangelo prosthetic hands, and liner and closu… Read more
Ottobock SE & Co. KGaA (OBCK) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Ottobock SE & Co. KGaA (OBCK) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ottobock SE & Co. KGaA - Net Assets Trend (None–None)
This chart illustrates how Ottobock SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ottobock SE & Co. KGaA (None–None)
The table below shows the annual net assets of Ottobock SE & Co. KGaA from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Ottobock SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Ottobock SE & Co. KGaA Competitors by Market Cap
The table below lists competitors of Ottobock SE & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The Connecticut Light and Power Company
PINK:CNTHP
|
$506.99K |
|
PAN AMER SILVER - Dusseldorf Stock Exchang
DU:PA2
|
$507.80K |
|
NANECH
ST:NANECH
|
$508.18K |
|
MASCO - Dusseldorf Stock Exchang
DU:MSQ
|
$508.23K |
|
BRIT AMER TOBACCO
MU:BMT
|
$506.17K |
|
Bessor Minerals Inc
PINK:TRYXF
|
$506.11K |
|
LEUCADIA NATIONAL
BE:LN3
|
$506.08K |
|
BA-P-A
PINK:BA-P-A
|
$505.89K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ottobock SE & Co. KGaA's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ottobock SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Ottobock SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Ottobock SE & Co. KGaA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ottobock SE & Co. KGaA (OBCK) | €- | N/A | N/A | $506.17K |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |